Northside Hospital, Inc. clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 3 with minor changes only.

1. Notable

   Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical…Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation

   Primary completion pushed from Jul 31, 2026 to Mar 31, 2027

   Also in this update: Study completion pushed from Dec 31, 2026 to Dec 31, 2027

   Northside Hospital, Inc.·Not specified· NCT05417971· Registry history of NCT05417971 on ClinicalTrials.gov (opens the registry)

   Updated Oct 14, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.